Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos N Papandreou

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
World Journal of Gastroenterology|June 5, 2009
Bone and brain metastases from ampullary adenocarcinomaIoannis A Voutsadakis, Stergios Doumas, Konstantinos Tsapakidis, et al.
Investigational New Drugs|May 7, 2013
Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent mannerPanagiotis J Vlachostergios, Eleana Hatzidaki, Christina D Befani, et al.
Clinical & Developmental Immunology|May 28, 2013
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesChristos Liaskos, Eirini I Rigopoulou, Timoklia Orfanidou, et al.
Cases Journal|January 12, 2010
AFP-producing hepatoid adenocarcinoma of the stomach: a case reportPanagiotis J Vlachostergios, Ioannis A Voutsadakis, Sotirios Barbanis, et al.
Cellular and Molecular Neurobiology|January 22, 2013
Bortezomib downregulates MGMT expression in T98G glioblastoma cellsPanagiotis J Vlachostergios, Eleana Hatzidaki, Nikolaos E Stathakis, et al.
Onkologie|September 15, 2010
Nonbacterial thrombotic (marantic) endocarditis in a patient with colorectal cancerPanagiotis J Vlachostergios, Danai D Daliani, Vassilis Dimopoulos, et al.
International Journal of Colorectal Disease|April 17, 2010
Additive inhibition of colorectal cancer cell lines by aspirin and bortezomibIoannis A Voutsadakis, Anna Patrikidou, Konstantinos Tsapakidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaLance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Cancer|September 5, 2002
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinomaDanai D Daliani, Christos N Papandreou, Peter F Thall, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 13, 2011
Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cellsChristina D Befani, Panagiotis J Vlachostergios, Eleana Hatzidaki, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
World Journal of Gastroenterology|June 5, 2009
Bone and brain metastases from ampullary adenocarcinomaIoannis A Voutsadakis, Stergios Doumas, Konstantinos Tsapakidis, et al.
Investigational New Drugs|May 7, 2013
Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent mannerPanagiotis J Vlachostergios, Eleana Hatzidaki, Christina D Befani, et al.
Clinical & Developmental Immunology|May 28, 2013
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesChristos Liaskos, Eirini I Rigopoulou, Timoklia Orfanidou, et al.
Cases Journal|January 12, 2010
AFP-producing hepatoid adenocarcinoma of the stomach: a case reportPanagiotis J Vlachostergios, Ioannis A Voutsadakis, Sotirios Barbanis, et al.
Cellular and Molecular Neurobiology|January 22, 2013
Bortezomib downregulates MGMT expression in T98G glioblastoma cellsPanagiotis J Vlachostergios, Eleana Hatzidaki, Nikolaos E Stathakis, et al.
Onkologie|September 15, 2010
Nonbacterial thrombotic (marantic) endocarditis in a patient with colorectal cancerPanagiotis J Vlachostergios, Danai D Daliani, Vassilis Dimopoulos, et al.
International Journal of Colorectal Disease|April 17, 2010
Additive inhibition of colorectal cancer cell lines by aspirin and bortezomibIoannis A Voutsadakis, Anna Patrikidou, Konstantinos Tsapakidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaLance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Cancer|September 5, 2002
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinomaDanai D Daliani, Christos N Papandreou, Peter F Thall, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 13, 2011
Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cellsChristina D Befani, Panagiotis J Vlachostergios, Eleana Hatzidaki, et al.
Pageof 6